Page results
-
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with mesothelioma, a rare and aggressive cancer of the lining of the lung.
-
UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.
-
Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.
-
The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.
-
The UCLH trauma and orthopaedics team has reached a milestone of 1000 operations on hips and knees using the Mako robot.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
File results
-
FOI/2022/0748 - Services closed at Trust due to staffing issues
-
FOI/2022/0751 - Pharmacy solution to remotely monitor fridge temperature
-
FOI/2022/0754 - Respiratory devices
-
FOI/2022/0763 - Treatment of dermatological conditions
-
FOI/2022/0769 - Non-disclosure agreement to resolve sexual harassment cases
-
FOI/2022/0778 - Phone calls to 09020 44 24 11 from NHS Trust
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0789 - Agencies (including off framework) used to supply locum agency doctors
-
FOI/2022/0795 - Mobile software (communications, chat, photo) used by the Trust
-
FOI/2022/0799 - Services outsourced to third parties for Finance, Payroll, Procurement